[HTML][HTML] Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies

Z Pang, R Raudonis, BR Glick, TJ Lin, Z Cheng - Biotechnology advances, 2019 - Elsevier
Pseudomonas aeruginosa is an opportunistic pathogen that is a leading cause of morbidity
and mortality in cystic fibrosis patients and immunocompromised individuals. Eradication of …

Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface

S Malhotra, D Hayes Jr, DJ Wozniak - Clinical microbiology …, 2019 - Am Soc Microbiol
In human pathophysiology, the clash between microbial infection and host immunity
contributes to multiple diseases. Cystic fibrosis (CF) is a classical example of this …

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection

AY Bhagirath, Y Li, D Somayajula, M Dadashi… - BMC pulmonary …, 2016 - Springer
Background The airways of patients with cystic fibrosis (CF) are highly complex, subject to
various environmental conditions as well as a distinct microbiota. Pseudomonas aeruginosa …

On-Line Analysis of Exhaled Breath: Focus Review

T Bruderer, T Gaisl, MT Gaugg, N Nowak… - Chemical …, 2019 - ACS Publications
On-line analysis of exhaled breath offers insight into a person's metabolism without the need
for sample preparation or sample collection. Due to its noninvasive nature and the possibility …

[HTML][HTML] Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy

AM Cantin, D Hartl, MW Konstan, JF Chmiel - Journal of Cystic Fibrosis, 2015 - Elsevier
Lung disease is the major cause of morbidity and mortality in patients with cystic fibrosis
(CF). Although CF lung disease is primarily an infectious disorder, the associated …

The interaction between respiratory pathogens and mucus

M Zanin, P Baviskar, R Webster, R Webby - Cell host & microbe, 2016 - cell.com
The interaction between respiratory pathogens and their hosts is complex and incompletely
understood. This is particularly true when pathogens encounter the mucus layer covering …

Pseudomonas aeruginosa: Recent Advances in Vaccine Development

M Killough, AM Rodgers, RJ Ingram - Vaccines, 2022 - mdpi.com
Pseudomonas aeruginosa is an important opportunistic human pathogen. Using its arsenal
of virulence factors and its intrinsic ability to adapt to new environments, P. aeruginosa …

Pseudomonas aeruginosa biofilm infections: community structure, antimicrobial tolerance and immune response

M Rybtke, LD Hultqvist, M Givskov… - Journal of molecular …, 2015 - Elsevier
Studies of biopsies from infectious sites, explanted tissue and medical devises have
provided evidence that biofilms are the underlying cause of a variety of tissue-associated …

CFTR: cystic fibrosis and beyond

MA Mall, D Hartl - 2014 - Eur Respiratory Soc
Cystic fibrosis (CF) remains the most common fatal hereditary lung disease. The discovery of
the cystic fibrosis transmembrane conductance regulator (CFTR) gene 25 years ago set the …

Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases

Z Zhou-Suckow, J Duerr, M Hagner, R Agrawal… - Cell and tissue …, 2017 - Springer
Airway mucus obstruction is a hallmark of many chronic lung diseases including rare genetic
disorders such as cystic fibrosis (CF) and primary ciliary dyskinesia, as well as common lung …